KORU MEDICAL SYSTEMS INC (KRMD) Fundamental Analysis & Valuation

NASDAQ:KRMD • US7599101026

Current stock price

4.33 USD
+0.15 (+3.59%)
At close:
4.3118 USD
-0.02 (-0.42%)
After Hours:

This KRMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. KRMD Profitability Analysis

1.1 Basic Checks

  • KRMD had negative earnings in the past year.
  • In the past year KRMD had a positive cash flow from operations.
  • KRMD had negative earnings in each of the past 5 years.
  • In the past 5 years KRMD reported 4 times negative operating cash flow.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

  • KRMD has a better Return On Assets (-9.35%) than 61.17% of its industry peers.
  • KRMD has a Return On Equity of -15.47%. This is in the better half of the industry: KRMD outperforms 63.30% of its industry peers.
Industry RankSector Rank
ROA -9.35%
ROE -15.47%
ROIC N/A
ROA(3y)-26.64%
ROA(5y)-22.29%
ROE(3y)-39.69%
ROE(5y)-31.84%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • With a decent Gross Margin value of 62.26%, KRMD is doing good in the industry, outperforming 65.96% of the companies in the same industry.
  • KRMD's Gross Margin has been stable in the last couple of years.
  • KRMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.16%
GM growth 5Y0.15%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KRMD Health Analysis

2.1 Basic Checks

  • KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KRMD has more shares outstanding than it did 1 year ago.
  • KRMD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for KRMD has been reduced compared to a year ago.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • KRMD has an Altman-Z score of 11.09. This indicates that KRMD is financially healthy and has little risk of bankruptcy at the moment.
  • KRMD has a better Altman-Z score (11.09) than 89.36% of its industry peers.
  • KRMD has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • KRMD has a better Debt to Equity ratio (0.00) than 72.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.09
ROIC/WACCN/A
WACC8.9%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • KRMD has a Current Ratio of 2.44. This indicates that KRMD is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.44, KRMD is in line with its industry, outperforming 44.68% of the companies in the same industry.
  • A Quick Ratio of 1.99 indicates that KRMD should not have too much problems paying its short term obligations.
  • KRMD has a Quick ratio of 1.99. This is comparable to the rest of the industry: KRMD outperforms 48.94% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 1.99
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. KRMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.00% over the past year.
  • Looking at the last year, KRMD shows a very strong growth in Revenue. The Revenue has grown by 22.23%.
  • Measured over the past years, KRMD shows a quite strong growth in Revenue. The Revenue has been growing by 11.21% on average per year.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)22.23%
Revenue growth 3Y13.81%
Revenue growth 5Y11.21%
Sales Q2Q%23.26%

3.2 Future

  • Based on estimates for the next years, KRMD will show a very strong growth in Earnings Per Share. The EPS will grow by 78.34% on average per year.
  • The Revenue is expected to grow by 16.15% on average over the next years. This is quite good.
EPS Next Y34.72%
EPS Next 2Y65.36%
EPS Next 3Y78.34%
EPS Next 5YN/A
Revenue Next Year18.24%
Revenue Next 2Y17.81%
Revenue Next 3Y16.15%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 -0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. KRMD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRMD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KRMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as KRMD's earnings are expected to grow with 78.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.36%
EPS Next 3Y78.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KRMD Dividend Analysis

5.1 Amount

  • KRMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KRMD Fundamentals: All Metrics, Ratios and Statistics

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (4/17/2026, 8:25:38 PM)

After market: 4.3118 -0.02 (-0.42%)

4.33

+0.15 (+3.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12
Earnings (Next)05-06
Inst Owners56.86%
Inst Owner Change0%
Ins Owners4.67%
Ins Owner Change8.5%
Market Cap205.63M
Revenue(TTM)41.13M
Net Income(TTM)-2.64M
Analysts80
Price Target6.94 (60.28%)
Short Float %1.79%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.23%
Min EPS beat(2)29.97%
Max EPS beat(2)50.49%
EPS beat(4)4
Avg EPS beat(4)51.26%
Min EPS beat(4)24.59%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)41.66%
EPS beat(12)12
Avg EPS beat(12)34.7%
EPS beat(16)15
Avg EPS beat(16)30.63%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)5.51%
Revenue beat(4)3
Avg Revenue beat(4)4.09%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)6.5%
Revenue beat(8)6
Avg Revenue beat(8)4.38%
Revenue beat(12)7
Avg Revenue beat(12)1.22%
Revenue beat(16)10
Avg Revenue beat(16)1.71%
PT rev (1m)3.03%
PT rev (3m)8.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-26.58%
EPS NY rev (1m)-313.33%
EPS NY rev (3m)-356%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5
P/FCF N/A
P/OCF 444.71
P/B 12.06
P/tB 12.57
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY0.22%
SpS0.87
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -9.35%
ROE -15.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.26%
FCFM N/A
ROA(3y)-26.64%
ROA(5y)-22.29%
ROE(3y)-39.69%
ROE(5y)-31.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.16%
GM growth 5Y0.15%
F-Score5
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 118.01%
Cap/Sales 2.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 1.99
Altman-Z 11.09
F-Score5
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)120.86%
Cap/Depr(5y)183.95%
Cap/Sales(3y)3.06%
Cap/Sales(5y)4.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y34.72%
EPS Next 2Y65.36%
EPS Next 3Y78.34%
EPS Next 5YN/A
Revenue 1Y (TTM)22.23%
Revenue growth 3Y13.81%
Revenue growth 5Y11.21%
Sales Q2Q%23.26%
Revenue Next Year18.24%
Revenue Next 2Y17.81%
Revenue Next 3Y16.15%
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.06%
EBIT Next 3Y67.48%
EBIT Next 5YN/A
FCF growth 1Y70.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y244.64%
OCF growth 3YN/A
OCF growth 5YN/A

KORU MEDICAL SYSTEMS INC / KRMD Fundamental Analysis FAQ

What is the fundamental rating for KRMD stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRMD.


What is the valuation status for KRMD stock?

ChartMill assigns a valuation rating of 1 / 10 to KORU MEDICAL SYSTEMS INC (KRMD). This can be considered as Overvalued.


What is the profitability of KRMD stock?

KORU MEDICAL SYSTEMS INC (KRMD) has a profitability rating of 2 / 10.